Real-time enrollment status for this hiv (human immunodeficiency virus) clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 2:12 AM UTC
| NCT Number | NCT07221123 |
| Recruiting Status | Recruiting |
| Condition | HIV (Human Immunodeficiency Virus) |
| Phase | PHASE2 |
| Target Enrollment | 80 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Alabama at Birmingham |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of July 18, 2026: Clinical trial NCT07221123 is currently recruiting participants. This phase2 study for hiv (human immunodeficiency virus) is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Alabama at Birmingham. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07221123 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07221123 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.